Bristol-Myers Squibb Company (BMY) recent quarterly performance of -13.25% is not showing the real picture

Bristol-Myers Squibb Company (NYSE: BMY) open the trading on March 16, 2023, with a bit cautious approach as it glided -0.56% to $67.10. During the day, the stock rose to $67.61 and sunk to $65.86 before settling in for the price of $67.48 at the close. Taking a more long-term approach, BMY posted a 52-week range of $65.28-$81.43.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 17.30%. Meanwhile, its Annual Earning per share during the time was 4.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -5.40%. This publicly-traded company’s shares outstanding now amounts to $2.11 billion, simultaneously with a float of $2.10 billion. The organization now has a market capitalization sitting at $142.54 billion. At the time of writing, stock’s 50-day Moving Average stood at $71.11, while the 200-day Moving Average is $73.45.

Bristol-Myers Squibb Company (BMY) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Bristol-Myers Squibb Company’s current insider ownership accounts for 0.07%, in contrast to 79.40% institutional ownership. According to the most recent insider trade that took place on Feb 06, this organization’s Board Chair and CEO sold 240,000 shares at the rate of 74.65, making the entire transaction reach 17,916,000 in total value, affecting insider ownership by 236,104. Preceding that transaction, on Feb 06, Company’s EVP, Chief Human Resources sold 11,183 for 74.69, making the whole transaction’s value amount to 835,258. This particular insider is now the holder of 23,043 in total.

Bristol-Myers Squibb Company (BMY) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 12/30/2022 suggests? It has posted $1.82 earnings per share (EPS) beating the forecaster’s viewpoint (set at $1.72) by $0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.11 per share during the current fiscal year.

Bristol-Myers Squibb Company’s EPS decrease for this current 12-month fiscal period is -5.40% and is forecasted to reach 8.21 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.06% through the next 5 years, which can be compared against the 4.50% growth it accomplished over the previous five years trading on the market.

Bristol-Myers Squibb Company (NYSE: BMY) Trading Performance Indicators

Let’s observe the current performance indicators for Bristol-Myers Squibb Company (BMY). It’s Quick Ratio in the last reported quarter now stands at 1.10. The Stock has managed to achieve an average true range (ATR) of 1.34. Alongside those numbers, its PE Ratio stands at $22.73, and its Beta score is 0.44. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.09. Similarly, its price to free cash flow for trailing twelve months is now 19.49.

In the same vein, BMY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.95, a figure that is expected to reach 2.00 in the next quarter, and analysts are predicting that it will be 8.21 at the market close of one year from today.

Technical Analysis of Bristol-Myers Squibb Company (BMY)

[Bristol-Myers Squibb Company, BMY] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 39.59% While, its Average True Range was 1.37.

Raw Stochastic average of Bristol-Myers Squibb Company (BMY) in the period of the previous 100 days is set at 11.29%, which indicates a major fall in contrast to 35.54% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 13.62% that was lower than 19.38% volatility it exhibited in the past 100-days period.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

Planet Fitness Inc. (PLNT) is heading in the right direction with an average volume of $913.99K

Planet Fitness Inc. (NYSE: PLNT) established initial surge of 1.44% at $76.71, as the Stock market unbolted on March 30, 2023. During the day,...

GrowGeneration Corp. (GRWG) recently have taken one step ahead with the beta value of 3.13

As on March 30, 2023, GrowGeneration Corp. (NASDAQ: GRWG) started slowly as it slid -2.99% to $3.24. During the day, the stock rose to...

A Little Luck Can Go a Long Way with Arcturus Therapeutics Holdings Inc. (ARCT) as it 5-day change was 36.69%

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) started the day on March 30, 2023, with a price increase of 2.33% at $20.64. During the day,...


Please enter your comment!
Please enter your name here